Most orally administered xenobiotics are metabolized first by the intestine and then by the liver after portal transport. The expression levels of enzymes involved in xenobiotic metabolism are regulated at the transcriptional level by key xenobiotic sensors including the steroid and xenobiotic receptor (SXR), also known as the pregnane X receptor (PXR), pregnane activated receptor (PAR) and NR1I2 (Bertilsson et al., 1998; Lehmann et al., 1998; Blumberg et al., 1998) . SXR is important in the field of toxicology for at least two reasons. Firstly, this receptor system induces the expression of CYP3A and CYP2B enzymes, the major metabolizers of pharmaceu- ABSTRACT -The human steroid and xenobiotic receptor (SXR), (also known as pregnane X receptor PXR, and NR1I2) is a low affinity sensor that responds to a variety of endobiotic, nutritional and xenobiotic ligands. SXR activates transcription of Cytochrome P450, family 3, subfamily A (CYP3A) and other important metabolic enzymes to up-regulate catabolic pathways mediating xenobiotic elimination. One key feature that demarcates SXR from other nuclear receptors is that the human and rodent orthologues exhibit different ligand preference for a subset of toxicologically important chemicals. This difference leads to a profound problem for rodent studies to predict toxicity in humans. The objective of this study is to generate a new humanized mouse line, which responds systemically to human-specific ligands in order to better predict systemic toxicity in humans. For this purpose, the ligand binding domain (LBD) of the human SXR was homologously knocked-in to the murine gene replacing the endogenous LBD. The LBD-humanized chimeric gene was expressed in all ten organs examined, including liver, small intestine, stomach, kidney and lung in a pattern similar to the endogenous gene expressed in the wild-type (WT) mouse. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis showed that the human-selective ligand, rifampicin induced Cyp3a11 and Carboxylesterase 6 (Ces6) mRNA expression in liver and intestine, whereas the murine-selective ligand, pregnenolone-16-carbonitrile did not. This new humanized mouse line should provide a useful tool for assessing whole body toxicity, whether acute, chronic or developmental, induced by human selective ligands themselves and subsequently generated metabolites that can trigger further toxic responses mediated secondarily by other receptors distributed body-wide.
INTRODUCTION
ticals and xenobiotics. Therefore, SXR is a key mediator of drug-and chemical-induced toxicity as well as drugdrug and drug-nutrient interactions (Zhou et al., 2004) . Secondly, the orthologous rodent and human receptors exhibit differential sensitivity for a subset of chemical ligands important in the field of toxicology. For example, rifampicin (RIF) is a specific and selective activator of human SXR, whereas pregnenolone 16a-carbonitrile (PCN) is selective for the rodent orthologue.
Rodent-human differences in CYP3A and CYP2B-mediated responses to xenobiotics can be a profound problem in toxicologic studies where rodents are used to predict the toxicity of a compound in humans (Ma et al., 2007) . Therefore, development of a murine model that reconstructs the SXR-mediated systemic response of humans is of a great significance in toxicology.
Human and rodent SXRs share ~95% amino acid sequence identity in the DNA-binding domain (DBD) but only about 77% identity in the LBD. Tirona et al. (2004) analyzed the ligand selectivity of a human-rat chimeric protein and showed that the species differences are primarily defined by sequence differences in the LBD. Watkins and colleagues showed that the key residues responsible for the majority of the ligand selectivity were Leu 308 (human) and Phe305 (rat and mouse). Crystallographic analysis located these amino acids within or neighboring the flexible loop that forms a part of the pore to the ligand-binding cavity. Swapping the rodent and human-specific residues was shown to modulate the activation by the human-selective activator RIF in vitro (Watkins et al., 2001) . According to those findings, a simple replacement of the mouse LBD with the human sequence should be sufficient to "humanize" the ligand binding properties as well as activation of the downstream target genes.
Three kinds of humanized mice have already been generated. One is the SXR-null/Alb-SXR mouse (Alb-SXR mouse) made by crossing the SXR knockout mice with a transgenic mouse line that expresses human SXR in liver under the control of the albumin promoter (Xie et al., 2000) . Gonzalez and colleagues generated a transgenic mouse expressing a human BAC containing the entire hSXR gene in a SXR null background, thus controlled under human SXR promoter (SXR BAC mouse) (Ma et al., 2007) . Another mouse is the human SXR genome knock-in mice (hSXR genome mouse) (Scheer et al., 2008) . The human SXR genomic region from exon 2 to exon 9 was knocked-in to mouse SXR exon 2. This mouse expresses the human full length SXR mRNA under the control of mouse SXR promoter regulation. Although useful for toxicology studies, these mice have disadvantages in that the human SXR is expressed only in the liver (Alb-SXR mouse), hSXR mRNA is not expressed in all of the tissues where SXR is known to be expressed (SXR BAC mouse), and there might be potential differences in the binding affinities of hSXR DNAbinding domain (DBD) to cis-acting elements in mouse SXR target genes (hSXR genome mouse).
As noted above, it is known that the critical differences between human and rodent ligand-selectivity reside in the LBD. Therefore, when our project to generate a humanized SXR mouse was initiated, we reasoned that altering the LBD would be sufficient to generate a humanized ligand selectivity. We decided to retain the mouse DBD to avoid any potential differences between the binding affinities of the chimeric receptor for cis-acting elements in the mouse genome. To maintain the tissue-specific expression pattern of the endogenous gene, we inserted the human cDNA encoding the region carboxyl-terminal to the DBD into the mouse gene. This retains all of the 5' and 3' regulatory elements in the mouse gene, as well as introns 1 and 2, which contain important elements for regulating SXR expression (Jung et al., 2006) .
Here we report a new line of mouse (hSXRki mouse) in which a cDNA encoding the human LBD is homologously recombined into the mouse gene after exon 3. The tissue distribution of the resulting chimeric mouse DBD-human LBD mRNA is comparable to that of the WT mouse. The hSXRki mouse showed a fully humanized response to the human-selective activator RIF in that the Cyp3a11 mRNA was induced in liver and mucosa of small intestine in response to RIF, but not the rodentselective compound PCN. This new mouse line should provide a useful tool for assessing the whole body toxicity induced by a human selective SXR ligand itself and its subsequently generated metabolite(s) that can trigger further toxic responses through other pathways body-wide.
MATERIALS AND METHODS

Generation of hSXRki knock-in mice
A DNA fragment of mouse SXR intron 2 to exon 3 was PCR amplified using mouse BAC DNA BAC clone No. RP23-351P21 as a template. Primers used were BAC39486FW and mSXR462RV (for sequences of the primers see Table1). This fragment was connected to the LBD of human SXR cDNA from amino acid 105 through the carboxyl terminus amplified by the PCR primers: hSXR904FW and hSXR1887RVEcoRI (template; human SXR cDNA). The 3'UTR of bovine growth hormone (BGH) was added to 3' to the terminal codon. This concatenated fragment was introduced to a vector, which has the neomycin resistance gene with loxP sequence at both ends, removable with Cre recombinase (Saga et al., 1999) . A 7kb KpnI fragment containing intron 2 was used as a long arm and 1.3kb PstI-EcoRI fragment containing from exon 8 to intron 8 was used as a short arm for homologous recombination (Fig. 1) . The resulting targeting vector was linearized with SacII and introduced by electroporation to TT2 ES cell line (Yagi et al., 1993) and neomycin resistant clones were selected, PCR genotyped, and confirmed by the Southern blotting. For generation of chimeric mice, these ES clones were aggregated with ICR 8-cell embryos and transferred to pseudopregnant female recipients. The chimeric mice born were bred with ICR females. Germ line transmission of the targeted allele was confirmed by PCR. A mouse was crossed with a CAG-Cre transgenic mouse (Sakai and Miyazaki, 1997) to evict the neomycin resistance gene, and back crossed to C57BL/6 CrSlc (SLC, Inc., Shizuoka, Japan) at least 6 generations and used for the analysis. Table 1 for primer sequences)
PCR Genotyping (See
Primers for identification of homologously recombined ES clones were NeoAL2 and SXR RC RV5. DNA purified from the tail of each mouse was used for PCR genotying. Primers for WT detection were WTInt5 and WTEx6RV amplifying a product of 755 bp. Primers for confirmation of removal of the neomycin resistance gene were mhSXRE4 and mhSXRSARV amplifying a product of 1,223 bp.
Southern blot analysis
To confirm homologous recombination, DNA from ES cell cultures was purified and digested with BamHI and XhoI, then electrophoresed and analyzed by Southern hybridization (Saga et al., 1997) . Mouse SXR exon 9 region which remains after homologous recombination was used for the probe. The restriction fragments from the WT allele and targeted allele are 2,305 bp and 1,925 bp, respectively.
Chemicals
RIF (molecular weight 822.95) and PCN (molecular weight 341.49) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Corn oil was purchased from Wako Pure Chemical Industries (Osaka, Japan). Table 1 for primer sequences)
Quantitative RT-PCR (Percellome PCR) (See
The method for Percellome quantitative RT-PCR was described previously (Kanno et al., 2006) . Briefly, tissue pieces stored in RNAlater (Ambion, Austin, TX, USA) were homogenized and lysed in RLT buffer (Qiagen GmbH., Germany) and 10 μl aliquots were used Targeting strategy used to generate the hSXRki mouse. The chimeric mouse DBD and human LBD fragment, followed by the BGH 3' UTR were knocked-in to the mouse SXR gene. The genomic region spanning from exon 3 to exon 8 was substituted by the inserted fragment with the remainder of the gene remaining intact. C) Confi rmation of homologous recombination by southern blot analysis. Six ES clones positive for recombination by PCR genotyping were further analyzed by southern blot (clones #4 ~ #101). Lower bands (1925 bp) indicate successful homologous recombination; upper bands (2305 bp) correspond to WT allele. Clones #4, #25, #32, #77 and #101 were confi rmed as homologous recombinants; clones #4 and #25 were used for the generation of chimeric mice. D) Confi rmation of Cre-mediated removal of the neomycin resistance gene. Mouse tail genome DNA was PCR amplifi ed with the primer set, mhSXRE4 and mhSXRSARV. *: 2,858 bp (for the mice having the neomycin resistance gene), **: 1,223 bp (for the mice without the neomycin resistance gene).
for genomic DNA quantification with PicoGreen fluorescent dye (Invitrogen, Carlsbad, CA, USA). A prepared spike mRNA cocktail solution containing known quantity of five mRNAs of bacillus subtilis was added to the tissue lysate in proportion to the DNA quantity. Total RNA was purified from the lysate using the RNeasy kit (Qiagen). One microgram of total RNA was reverse-transcribed with SuperScript II (Invitrogen). Quantitative real time PCR was performed with an ABI PRISM 7900 HT sequence detection system (Applied Biosystems) using SYBR Green PCR Master Mix (Applied Biosystems), with initial denaturation at 95°C for 10 min followed by 40 cycles of 30 sec at 95°C and 30 sec at 60°C and 30 sec at 72°C, and Ct values were obtained. Primers for Cyp3a11 were Cyp3a11 FW and Cyp3a11 RV. Primers for Ces6 were Ces6 FW and Ces6 RV. Primers for mouse SXR selective quantifi cation were mouse SXR FW and mouse SXR RV. Primers for hSXRki selective quantifi cation were human SXR FW and human SXR RV. Primers for both mouse SXR and hSXRki quantifi cation were mouse-human SXR FW and mouse-human SXR RV that amplify the DBD region of the chimera.
In Situ Hybridization analysis
Digoxigein-labeled cRNA probe for Cyp3a11 was synthesized according to Suzuki et al. (2005) by RT-PCR using mouse liver cDNA as a template. The primers used were as follows: forward 5'-GATTGGTTTTGATGCCT-GGT-3' and reverse 5'-CAAGAGCTCACATTTTTCAT-CA-3'. The amplified product was sequence confirmed and ligated with Block-iT T7-TOPO (Invitrogen) Linker, which contains the T7 promoter site. A secondary PCR was performed to generate the sense and antisense DNA templates. For antisense template, Block-iT T7 Primer and Cyp3a11 forward primer (or reverse primer for generation of sense DNA template), the same primer as for the fi rst PCR amplifi cation, were used. With these DNA templates, both sense and antisense digoxigenin-labeled riboprobes were synthesized using a DIG RNA labeling kit (Roche Diagnostics, Germany) according to the manufacturer's protocol.
ISH on paraffi n sections was carried out according to Suzuki et al. with a modifi cation; permeabilization condition 98°C for 15 min in HistoVT One (Nacalai tesque, Japan).
Animals experiments
Male hSXRki and WT mice were maintained under a 12 hr light/12 hr dark cycle with water and chow (CRF-1, Oriental Yeast Co. Ltd., Tokyo, Japan) provided ad libitum. The animal studies were conducted in accordance with the Guidance for Animal Studies of the National Institute of Health Sciences under Institutional approval. The expression level of the hSXRki and WT SXR mRNA of ten organs (brain, thymus, heart, lung, liver, stomach, spleen, kidney, small intestine and testis) were analyzed on 15 weeks old male mice (n = 2) by the Percellome quantitative RT-PCR.
For the demonstration of selective gene induction by RIF and PCN in hSXRki and WT male mice on 13 weeks old, three mice per group were singly dosed orally with vehicle (corn oil+0.1% DMSO), 10, 30, or 100 mg/kg of RIF, or 20, 70, or 200 mg/kg PCN (approximately equivalent in molar dose). Eight hours later, mice were sacrifi ced by exsanguination under ether anesthesia and the liver and the small intestine mucosa were sampled. Liver samples in small pieces were stored in RNA later (Applied Biosystems, Foster City, CA, USA) for further analysis. The small intestine under ice-cooled condition was longitudinally opened, gently rinsed with RNase-free saline and the epithelium was scraped with a glass slide and immersed in RNAlater. For in situ hybridization (ISH) of Cyp3a11 in the liver, 15 weeks old male hSXRki and WT mice were dosed orally with vehicle (corn oil), RIF (10 mg/kg), or PCN (40 mg/kg) daily for 3 days and liver sampled 24 hr later. All mice were sacrifi ced by exsanguination under ether anesthesia.
Statistical analysis
All values are expressed as the means ± S.D. and group differences analyzed by unpaired Student's t test or oneway ANOVA followed by Dunnett's post hoc comparison. Level of signifi cance was set at p < 0.05.
RESULTS
Generation of hSXRki knock-In mice
Among 144 neomycin resistant TT2 ES clones, six PCR positive clones were further submitted to Southern blotting for the confi rmation of homologous recombination. As shown in Fig. 1C , five clones were confirmed, and two (#4 and #25) were used to generate chimeric mice. The resulting mice were backcrossed to ICR strain to confirm germline transmission. One clone (#4) was crossed to a mouse constitutively expressing Cre recombinase to remove the neomycin resistance gene (Fig. 1D ) and backcrossed to C57BL/6 CrSlc for at least 6 generations before further analysis.
Tissue distribution of hSXRki mRNA
Ten tissues, i.e., brain, thymus, heart, lung, liver, stomach, spleen, kidney, small intestine and testis from both hSXRki and WT mice were measured for hSXRki or WT SXR mRNA expression by the Percellome quantitative RT-PCR. As shown in Fig. 2 , the levels of hSXRki mRNA are comparable to that of SXR in WT mouse and expressed in all tissues analyzed.
Humanized responses in hSXRki mouse
Humanized response of hSXRki was demonstrated by administration of the mouse-specifi c ligand PCN and the Percellome quantitative RT-PCR data of Cyp3a11 and Ces6, both known as SXR target genes, in liver and small intestinal mucosa showed humanized responses in hSXRki. Bars = S.D., *; p < 0.05, **; p < 0.01 compared with vehicle group of WT, #; p < 0.05, ##; p < 0.01 compared with vehicle group of hSXRki. Analyzed by one-way ANOVA followed by Dunnett's post hoc comparison. Level of signifi cance was set at p < 0.05.
human-specifi c ligand RIF to the mice. Induction of the well-known SXR-regulated genes, Cyp3a11 and Ces6 was monitored by Percellome quantitative RT-PCR. As shown in Fig. 3 , in the liver and small intestinal mucosa, RIF, but not PCN, induced Cyp3a11 and Ces6 in hSXRki mice (closed column), whereas PCN exclusively induced these genes in WT mice (open column). ISH of Cyp3a11 of the liver also showed humanized responses in hSXRki mice (Fig. 4) .
DISCUSSION
We generated a new humanized mouse model in which the ligand binding domain (LBD) of human SXR was homologously knocked-into the murine SXR gene so that systemic response induced by human-selective SXR ligands can be monitored in mice. Firstly, we showed that mRNA from this chimeric gene was expressed at appropriate levels in the same tissues as the endogenous mouse SXR gene in WT mice. Then the humanized response of the mouse was confi rmed by monitoring its response to the human-selective activator RIF, and the lack of response to the rodent-selective activator PCN. There are relatively few reports about the regulation of SXR expression to date. Aouabdi et al. (2006) reported the presence of a PPAR alpha binding site 2.2 kb upstream of the transcription start site in human SXR. This site corresponded to the induction site with clofibrate in the rat and they further confirmed its importance using human liver cancer cell line (Huh7). Jung et al. (2006) reported the presence of four FXR binding sites in intron 2 of the mouse SXR gene that were required for FXR regulation of SXR expression. This intron 2 region is completely intact in our hSXRki mouse. Therefore, the regulation by FXR should be preserved in our mice.
Compared to the previously generated humanized Alb-SXR, SXR BAC, and hSXR genome mice, we contend that our hSXRki mouse has an advantage because the human-mouse chimeric gene is expressed in the same tissues and at similar levels to endogenous SXR in WT mice under control of the mouse promoter. This feature would make this model suitable not only for systemic toxicity but also toxicity at various stages of development of the embryo and fetus, maturation of infant, and of senescence, where the cis and trans regulations might be critical in its regulation (Sarsero et al., 2004) (Konopka et al., 2009) . Thus, we believe that our system has a broader application range for toxicological studies.
